Global Compliance

Premier Research Names Ellen Teplitzky Chief Compliance Officer and SVP of Legal Affairs

MORRISVILLE, N.C., April 8, 2021 Premier Research, the clinical research company that’s Built for Biotech℠, today announced the appointment of Ellen Teplitzky as Chief Compliance Officer and Senior Vice President, Legal Affairs.

Since joining Premier Research six years ago, Ms. Teplitzky has been instrumental in streamlining the customer contracting process and managing requirements associated with the European Union’s General Data Protection Regulation (GDPR) among other successes. In her new role, she will be responsible for establishing standards and implementing procedures that ensure the highest level of global compliance for Premier’s biotech and specialty pharma sponsors.

“From day one six years ago, Ellen has supported our customers in so many ways by continuously monitoring changes in the legal and regulatory landscape and proactively seeking out and implementing effective solutions,” said Premier Research Chief Commercial Offer Sean Russell. “Now she has stepped up to direct our global compliance efforts just as this function has become more critical than ever to our sponsors and regulators.”

Ms. Teplitzky began her legal career in private practice and transitioned into government service. She earned a Master of Law with a specialty designation in law and development, awarded with merit from the University of London. She also holds a bachelor’s in history from Emory College, and a J.D. from the Emory University School of Law.

About Premier Research

Premier Research, a clinical research company, is dedicated to helping biotech, specialty pharma, and device innovators transform life-changing ideas and breakthrough science into new medical treatments.

As a global company, Premier Research specializes in the use of innovative technologies for smart study design and trial management to deliver clean, conclusive data to sponsors.

Whether it’s developing product lifecycle strategies, reducing clinical development cycle times, securing access to patients, navigating global regulations, maximizing the impact of limited rare disease data, or providing expertise in specific therapeutic areas, Premier Research is committed to helping its customers answer the unmet needs of patients across a broad range of medical conditions.